At Axcellant, our Pharmacovigilance and Product Safety services ensure the highest level of patient safety and regulatory compliance throughout the clinical research process. By integrating proactive adverse event monitoring with robust risk management strategies, we safeguard public health and support informed decision-making in every trial.
How Axcellant Defines Pharmacovigilance Services
At Axcellant, pharmacovigilance means a comprehensive approach to safety in clinical trials. We focus on patient safety by continuously monitoring adverse events and implementing effective drug risk management practices. Our commitment is to ensure that every aspect of safety—from clinical data review to risk evaluation—contributes to a secure and reliable research environment.
Monitoring Safety with Axcellant’s Pharmacovigilance Process
Our process is designed to deliver reliable safety monitoring and actionable insights:
- Proactive Risk Monitoring: We employ advanced systems to monitor, detect, and analyze adverse events and safety signals in real time, ensuring rapid and effective responses.
- Patient-Centric Safety Practices: We prioritize patient welfare by implementing stringent safety protocols and maintaining vigilant oversight throughout the trial.
- Regulatory Compliance: To maintain product safety and regulatory approval, we ensure full adherence to international pharmacovigilance regulations, including ICH guidelines and local requirements.
- Safety Reporting: We ensure the collection, documentation, and communication of safety data to all relevant stakeholders.
- Adverse Event Tracking: We conduct continuous monitoring and detailed tracking of adverse events throughout clinical trials.
- Risk-Benefit Analysis: We systematically evaluate the risk-benefit profile of investigational products.
- Signal Detection: We leverage advanced analytics to identify early safety signals.
Pharmacovigilance Services
Axcellant offers a comprehensive suite of pharmacovigilance services, including:
- Safety Monitoring and Management: Identifying, evaluating, and addressing safety signals to ensure early intervention and risk reduction.
- Safety Reporting: Preparing comprehensive safety reports for regulatory submissions and ongoing compliance, including Development Safety Update Reports (DSURs) and Periodic Safety Update Reports (PSURs).
- Risk Assessment: In-depth evaluation of potential risks associated with investigational products.
- Pharmacovigilance Systems: Deploying and managing cutting-edge systems to capture and analyze safety data.
- Post-Marketing Surveillance: Conducting long-term safety monitoring and assessments after product approval to ensure patient safety.
- Regulatory Support and Submissions: Providing expert guidance and documentation for pharmacovigilance-related regulatory submissions.
- Compliance Reporting: Preparing detailed documentation and reporting that meets stringent regulatory requirements.
Partner with Axcellant for Comprehensive Safety Monitoring
Partner with Axcellant to ensure comprehensive safety monitoring and robust risk management in your clinical trials. Our pharmacovigilance expertise, combined with dedicated regulatory support, empowers you to advance your research with confidence. Reach out today to learn more about our tailored services.